Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT06472388
Title Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors (EVENET)
Acronym EVENET
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors AC Camargo Cancer Center
Indications
Therapies
Age Groups: adult | senior | child
Covered Countries


No variant requirements are available.